歡迎光臨源葉生物,登錄 | 注冊 |
當(dāng)前位置: 首頁 > 小分子抑制劑 > GPCR/GProtein > Fenoldopam Mesylate

瀏覽歷史

S80884

Fenoldopam Mesylate

源葉(MedMol) 99%
  • 英文名:
  • Fenoldopam Mesylate
  • 別名:
  • CAS號:
  • 67227-57-0
  • 分子式:
  • C17H20ClNO6S
  • 分子量:
  • 401.86
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S80884-5mg 99% ¥220.00元 >10 - - - EA 加入購物車
源葉(MedMol) S80884-10mg 99% ¥420.00元 >10 - - - EA 加入購物車
源葉(MedMol) S80884-50mg 99% ¥1470.00元 >10 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述:

    Fenoldopam mesylate (SKF-82526) is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor (IC50=0.8974 μM). Fenoldopam mesylate shows anti-hypertensive effects, anti-cancer cell proliferation activity and can induce cells apoptosis

  • 靶點: IC50: 0.8974 μM (LSD1);DopamineReceptor
  • 體內(nèi)研究:
    Fenoldopam mesylate (subcutaneous injection; 100 mg/kg; once daily; 2 d) can induce arteritis in rats detected by magnetic resonance imaging (MRI)
  • 參考文獻:
    1. A Grenader, et al. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. J Pharmacol Exp Ther. 1991 Jul 1;258(1):193-8. 2. Yan Zheng, et al. Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy. Bioorg Chem. 2021 Mar;108:104561. 3. Yuta Fujii, et al. Detection of fenoldopam-induced arteritis in rats using ex vivo / in vivo MRI. Toxicology Reports, Volume 9, 2022, Pages 1595-1602.
  • 溶解性: Soluble  in  DMSO、H2O
  • 保存條件: RT
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.488 ml 12.442 ml 24.884 ml
    5 mM 0.498 ml 2.488 ml 4.977 ml
    10 mM 0.249 ml 1.244 ml 2.488 ml
    50 mM 0.05 ml 0.249 ml 0.498 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述:

    Fenoldopam mesylate (SKF-82526) is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor (IC50=0.8974 μM). Fenoldopam mesylate shows anti-hypertensive effects, anti-cancer cell proliferation activity and can induce cells apoptosis

  • 靶點: IC50: 0.8974 μM (LSD1);DopamineReceptor
  • 體內(nèi)研究:
    Fenoldopam mesylate (subcutaneous injection; 100 mg/kg; once daily; 2 d) can induce arteritis in rats detected by magnetic resonance imaging (MRI)
  • 參考文獻:
    1. A Grenader, et al. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. J Pharmacol Exp Ther. 1991 Jul 1;258(1):193-8. 2. Yan Zheng, et al. Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy. Bioorg Chem. 2021 Mar;108:104561. 3. Yuta Fujii, et al. Detection of fenoldopam-induced arteritis in rats using ex vivo / in vivo MRI. Toxicology Reports, Volume 9, 2022, Pages 1595-1602.
  • 溶解性: Soluble  in  DMSO、H2O
  • 保存條件: RT
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.488 ml 12.442 ml 24.884 ml
    5 mM 0.498 ml 2.488 ml 4.977 ml
    10 mM 0.249 ml 1.244 ml 2.488 ml
    50 mM 0.05 ml 0.249 ml 0.498 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。
点击收缩